1. Examine data supporting a patient survival advantage for the Ross procedure compared to other aortic valve operations.

2. Examine and define the technical success factors required for a life-long lasting functional autograft.

3. Examine data on the impact of decellularization on pulmonary allograft function and durability.

4. Examine strategies to restore the Ross procedure to the surgical "menu" of aortic valve operations.

Mr. Donald N. Ross, FRCS
London, United Kingdom

Prof. Sir Magdi Yacoub, FRCS, FRS
Imperial College London
Heart Science Center
London, United Kingdom

Traveling with Prof. Sir Yacoub:
Ismail El-Hamamsy, M.D., MSc, FRCSC

Emile A Bacha, M.D.
Childrens Hospital Boston
Boston, MA

Prof. John W. Brown, M.D.
Indiana University
Indianapolis, IN

Prof. Francisco da Costa, M.D.
Santa Casa de Curitiba
Curitiba, Brazil

Steven Goldstein, Ph.D.
Senior Director, Tissue Technologies
CryoLife, Inc.
Kennesaw, Ga

Prof. Neal Kon, M.D.
Wake Forest University
Winston-Salem, NC

Giovanni Battista Luciani, M.D.
University of Verona
Verona, Italy

Prof. Hans Sievers, M.D., FETCS
Klinik für Herzchirurgie
Luebeck, Germany

Paul Stelzer, M.D.
Mt. Sinai Hospital
New York, NY

Hanneke Takkenberg, M.D., Ph.D.
Erasmus University
Rotterdam, Netherlands

Traveling with Dr. Takkenberg:
Menno van Gameren, M.D.

Michael F. Teodori, M.D.
Phoenix Childrens Hospital
Phoenix, AZ

Prof. Ross Ungerleider, M.D.
Oregon Health & Science University
Portland, OR

Kent E. Ward, M.D.
University of Oklahoma
Oklahoma City, OK